REGENERON PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Receivable
REGENERON PHARMACEUTICALS, INC. (REGN) reported Increase (Decrease) in Accounts Receivable of $837.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $838.50M, a 2873.40% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$1.20M.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $51.20M, a 56.54% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $80.30M, a 79.35% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$498.10M, a 189.91% decline from fiscal 2024.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $554.00M, a 63.52% increase from fiscal 2023.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2023 was $338.80M.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2022 was -$707.80M, a 136.72% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $838.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $837.30M 10-Q · filed 2026-07-30 | $888.50M derived: sum of 3 quarters · filed 2026-07-30 | $968.80M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$1.20M 10-Q · filed 2026-04-29 | $50.00M derived: sum of 2 quarters · filed 2026-04-29 | $130.30M derived: sum of 3 quarters · filed 2026-04-29 | $158.50M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $51.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $131.50M derived: sum of 2 quarters · filed 2026-02-04 | $159.70M derived: sum of 3 quarters · filed 2026-07-30 | -$498.10M 10-K · filed 2026-02-04 | ||||
| 2025-09-30 | $80.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $108.50M derived: sum of 2 quarters · filed 2026-07-30 | -$549.30M 10-Q · filed 2025-10-28 | -$431.50M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $28.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$629.60M 10-Q · filed 2026-07-30 | -$511.80M derived: sum of 3 quarters · filed 2026-07-30 | -$122.90M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$657.80M 10-Q · filed 2026-04-29 | -$540.00M derived: sum of 2 quarters · filed 2026-04-29 | -$151.10M derived: sum of 3 quarters · filed 2026-04-29 | $343.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $117.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $506.70M derived: sum of 2 quarters · filed 2026-02-04 | $1.00B derived: sum of 3 quarters · filed 2026-02-04 | $554.00M 10-K · filed 2026-02-04 | ||||
| 2024-09-30 | $388.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $883.00M derived: sum of 2 quarters · filed 2025-10-28 | $436.20M 10-Q · filed 2025-10-28 | $518.90M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-06-30 | $494.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $47.30M 10-Q · filed 2025-08-01 | $130.00M derived: sum of 3 quarters · filed 2026-02-04 | $593.50M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-03-31 | -$446.80M 10-Q · filed 2025-04-29 | -$364.10M derived: sum of 2 quarters · filed 2026-02-04 | $99.40M derived: sum of 3 quarters · filed 2026-02-04 | $102.10M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2023-12-31 | $82.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $546.20M derived: sum of 2 quarters · filed 2026-02-04 | $548.90M derived: sum of 3 quarters · filed 2026-02-04 | $338.80M 10-K · filed 2026-02-04 | ||||
| 2023-09-30 | $463.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $466.20M derived: sum of 2 quarters · filed 2024-10-31 | $256.10M 10-Q · filed 2024-10-31 | $36.50M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$207.40M 10-Q · filed 2024-08-01 | -$427.00M derived: sum of 3 quarters · filed 2025-02-05 | -$40.10M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-03-31 | -$210.10M 10-Q · filed 2024-05-02 | -$429.70M derived: sum of 2 quarters · filed 2025-02-05 | -$42.80M derived: sum of 3 quarters · filed 2025-02-05 | $279.60M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2022-12-31 | -$219.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $167.30M derived: sum of 2 quarters · filed 2025-02-05 | $489.70M derived: sum of 3 quarters · filed 2025-02-05 | -$707.80M 10-K · filed 2025-02-05 | ||||
| 2022-09-30 | $386.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $709.30M derived: sum of 2 quarters · filed 2023-11-02 | -$488.20M 10-Q · filed 2023-11-02 | $96.30M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-06-30 | $322.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$875.10M 10-Q · filed 2023-08-03 | -$290.60M derived: sum of 3 quarters · filed 2024-02-05 | -$1.83B derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-03-31 | -$1.20B 10-Q · filed 2023-05-04 | -$613.00M derived: sum of 2 quarters · filed 2024-02-05 | -$2.15B derived: sum of 3 quarters · filed 2024-02-05 | $671.60M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2021-12-31 | $584.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | -$956.50M derived: sum of 2 quarters · filed 2024-02-05 | $1.87B derived: sum of 3 quarters · filed 2024-02-05 | $1.93B 10-K · filed 2024-02-05 | ||||
| 2021-09-30 | -$1.54B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.28B derived: sum of 2 quarters · filed 2022-11-03 | $1.34B 10-Q · filed 2022-11-03 | $1.42B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-06-30 | $2.83B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $2.88B 10-Q · filed 2022-08-03 | $2.96B derived: sum of 3 quarters · filed 2023-02-06 | $4.19B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-03-31 | $58.30M 10-Q · filed 2022-05-04 | $139.10M derived: sum of 2 quarters · filed 2023-02-06 | $1.37B derived: sum of 3 quarters · filed 2023-02-06 | $1.25B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2020-12-31 | $80.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | $1.31B derived: sum of 2 quarters · filed 2023-02-06 | $1.19B derived: sum of 3 quarters · filed 2023-02-06 | $1.36B 10-K · filed 2023-02-06 | ||||
| 2020-09-30 | $1.23B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.11B derived: sum of 2 quarters · filed 2021-11-04 | $1.28B 10-Q · filed 2021-11-04 | $1.33B derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-06-30 | -$121.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $47.10M 10-Q · filed 2021-08-05 | $106.30M derived: sum of 3 quarters · filed 2022-02-07 | $323.30M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-03-31 | $169.00M 10-Q · filed 2021-05-06 | $228.20M derived: sum of 2 quarters · filed 2022-02-07 | $445.20M derived: sum of 3 quarters · filed 2022-02-07 | $601.60M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2019-12-31 | $59.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | $276.20M derived: sum of 2 quarters · filed 2022-02-07 | $432.60M derived: sum of 3 quarters · filed 2022-02-07 | $523.70M 10-K · filed 2022-02-07 | $473.10M 10-K · filed 2020-02-07 | |||
| 2019-09-30 | $217.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $373.40M derived: sum of 2 quarters · filed 2020-11-05 | $464.50M 10-Q · filed 2020-11-05 | $460.90M 10-Q · filed 2019-11-05 | $472.30M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-06-30 | $156.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $247.50M 10-Q · filed 2020-08-05 | $256.80M 10-Q · filed 2019-08-06 | $255.30M derived: sum of 3 quarters · filed 2021-02-08 | $419.00M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-03-31 | $91.10M 10-Q · filed 2020-05-05 | $106.10M 10-Q · filed 2019-05-07 | $98.90M derived: sum of 2 quarters · filed 2021-02-08 | $262.60M derived: sum of 3 quarters · filed 2021-02-08 | $357.90M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2018-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $171.50M derived: sum of 2 quarters · filed 2021-02-08 | $266.80M derived: sum of 3 quarters · filed 2021-02-08 | $236.40M 10-K · filed 2021-02-08 | $268.90M 10-K · filed 2019-02-07 | |||
| 2018-09-30 | $163.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $259.00M derived: sum of 2 quarters · filed 2019-11-05 | $228.60M 10-Q · filed 2019-11-05 | $228.60M 10-Q · filed 2018-11-06 | $231.47M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-06-30 | $95.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $64.90M 10-Q · filed 2019-08-06 | $64.91M 10-Q · filed 2018-08-02 | $67.77M derived: sum of 3 quarters · filed 2020-02-07 | $194.67M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-03-31 | -$30.40M 10-Q · filed 2019-05-07 | -$30.41M 10-Q · filed 2018-05-03 | -$27.53M derived: sum of 2 quarters · filed 2020-02-07 | $99.37M derived: sum of 3 quarters · filed 2020-02-07 | $194.37M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | $2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $129.77M derived: sum of 2 quarters · filed 2020-02-07 | $224.77M derived: sum of 3 quarters · filed 2020-02-07 | $362.70M 10-K · filed 2020-02-07 | $362.72M 10-K · filed 2018-02-08 | |||
| 2017-09-30 | $126.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $221.90M derived: sum of 2 quarters · filed 2018-11-06 | $359.83M 10-Q · filed 2018-11-06 | $327.55M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-06-30 | $95.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $232.93M 10-Q · filed 2018-08-02 | $200.65M derived: sum of 3 quarters · filed 2019-02-07 | $92.55M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-03-31 | $137.93M 10-Q · filed 2018-05-03 | $105.65M derived: sum of 2 quarters · filed 2019-02-07 | -$2.45M derived: sum of 3 quarters · filed 2019-02-07 | -$115.70M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2016-12-31 | -$32.28M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | -$140.38M derived: sum of 2 quarters · filed 2019-02-07 | -$253.63M derived: sum of 3 quarters · filed 2019-02-07 | $143.80M 10-K · filed 2019-02-07 | $143.83M 10-K · filed 2017-02-09 | |||
| 2016-09-30 | -$108.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$221.35M derived: sum of 2 quarters · filed 2017-11-08 | $176.08M 10-Q · filed 2017-11-08 | $204.56M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | -$113.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $284.18M 10-Q · filed 2017-08-03 | $312.66M derived: sum of 3 quarters · filed 2018-02-08 | $356.85M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | $397.43M 10-Q · filed 2017-05-04 | $425.91M derived: sum of 2 quarters · filed 2018-02-08 | $470.10M derived: sum of 3 quarters · filed 2018-02-08 | $559.10M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2015-12-31 | $28.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | $72.67M derived: sum of 2 quarters · filed 2018-02-08 | $161.68M derived: sum of 3 quarters · filed 2018-02-08 | $491.42M 10-K · filed 2018-02-08 | ||||
| 2015-09-30 | $44.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $133.20M derived: sum of 2 quarters · filed 2016-11-04 | $462.94M 10-Q · filed 2016-11-04 | $551.51M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-06-30 | $89.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $418.75M 10-Q · filed 2016-08-04 | $507.32M derived: sum of 3 quarters · filed 2017-02-09 | $538.46M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-03-31 | $329.75M 10-Q · filed 2016-05-05 | $321.06M 10-Q · filed 2015-05-07 | $418.31M derived: sum of 2 quarters · filed 2017-02-09 | $449.45M derived: sum of 3 quarters · filed 2017-02-09 | $272.14M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2014-12-31 | $88.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $119.70M derived: sum of 2 quarters · filed 2017-02-09 | -$57.60M derived: sum of 3 quarters · filed 2017-02-09 | $34.93M 10-K · filed 2017-02-09 | $62.43M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $31.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$146.17M derived: sum of 2 quarters · filed 2015-11-04 | -$53.64M 10-Q · filed 2015-11-04 | -$27.71M 10-Q · filed 2014-11-04 | -$158.98M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-06-30 | -$177.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$84.78M 10-Q · filed 2015-08-04 | -$61.04M 10-Q · filed 2014-08-05 | -$190.11M derived: sum of 3 quarters · filed 2016-02-11 | -$45.45M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-03-31 | $92.53M 10-Q · filed 2015-05-07 | -$12.81M derived: sum of 2 quarters · filed 2016-02-11 | $131.85M derived: sum of 3 quarters · filed 2016-02-11 | $220.22M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | -$105.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $39.32M derived: sum of 2 quarters · filed 2016-02-11 | $127.69M derived: sum of 3 quarters · filed 2016-02-11 | $245.47M 10-K · filed 2016-02-11 | $198.66M 10-K · filed 2014-02-13 | |||
| 2013-09-30 | $144.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $233.03M derived: sum of 2 quarters · filed 2014-11-04 | $350.81M 10-Q · filed 2014-11-04 | $299.70M 10-Q · filed 2013-11-05 | $440.97M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2013-06-30 | $88.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $206.15M 10-Q · filed 2014-08-05 | $182.90M 10-Q · filed 2013-08-06 | $296.31M derived: sum of 3 quarters · filed 2015-02-12 | $462.20M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2013-03-31 | $117.78M 10-Q · filed 2014-05-08 | $109.52M 10-Q · filed 2013-05-03 | $207.94M derived: sum of 2 quarters · filed 2015-02-12 | $373.83M derived: sum of 3 quarters · filed 2015-02-12 | $570.87M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2012-12-31 | $90.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $256.05M derived: sum of 2 quarters · filed 2015-02-12 | $453.09M derived: sum of 3 quarters · filed 2015-02-12 | $588.40M 10-K · filed 2015-02-12 | $590.09M 10-K · filed 2013-02-15 | |||
| 2012-09-30 | $165.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $362.92M derived: sum of 2 quarters · filed 2013-11-05 | $498.24M 10-Q · filed 2013-11-05 | $524.29M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-06-30 | $197.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $332.35M 10-Q · filed 2013-08-06 | $358.40M derived: sum of 3 quarters · filed 2014-02-13 | $352.32M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-03-31 | $135.31M 10-Q · filed 2013-05-03 | $161.36M derived: sum of 2 quarters · filed 2014-02-13 | $155.29M derived: sum of 3 quarters · filed 2014-02-13 | $152.11M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2011-12-31 | $26.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $19.98M derived: sum of 2 quarters · filed 2014-02-13 | $16.80M derived: sum of 3 quarters · filed 2014-02-13 | $21.12M 10-K · filed 2014-02-13 | ||||
| 2011-09-30 | -$6.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | -$9.25M derived: sum of 2 quarters · filed 2012-10-24 | -$4.93M 10-Q · filed 2012-10-24 | -$14.66M 10-Q · filed 2011-10-27 | -$4.13M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-06-30 | -$3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $1.14M 10-Q · filed 2012-07-25 | -$8.55M 10-Q · filed 2011-07-28 | $1.94M derived: sum of 3 quarters · filed 2013-02-15 | -$10.97M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-03-31 | $4.32M 10-Q · filed 2012-04-26 | -$4.96M 10-Q · filed 2011-05-03 | $5.12M derived: sum of 2 quarters · filed 2013-02-15 | -$7.79M derived: sum of 3 quarters · filed 2013-02-15 | $15.54M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2010-12-31 | $799.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | -$12.11M derived: sum of 2 quarters · filed 2013-02-15 | $11.23M derived: sum of 3 quarters · filed 2013-02-15 | $17.52M 10-K · filed 2013-02-15 | $27.54M 10-K · filed 2011-02-17 | |||
| 2010-09-30 | -$12.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $10.43M derived: sum of 2 quarters · filed 2011-10-27 | $16.72M 10-Q · filed 2011-10-27 | $14.66M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-06-30 | $23.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $29.63M 10-Q · filed 2011-07-28 | $27.57M derived: sum of 3 quarters · filed 2012-02-21 | $35.29M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | $6.29M 10-Q · filed 2011-05-03 | $4.23M derived: sum of 2 quarters · filed 2012-02-21 | $11.95M derived: sum of 3 quarters · filed 2012-02-21 | |||||
| 2009-12-31 | -$2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $5.66M derived: sum of 2 quarters · filed 2012-02-21 | $30.49M 10-K · filed 2012-02-21 | $30.36M 10-K · filed 2011-02-17 | ||||
| 2009-09-30 | $7.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $32.55M 10-Q · filed 2010-10-28 | ||||||
| 2009-06-30 | $24.83M 10-Q · filed 2010-07-28 | |||||||
| 2008-12-31 | $16.89M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |